Home
Cullinan Therapeutics

Cullinan Therapeutics Market Share Analysis for March 2026

Review our privacy notice. This includes important information on forward-looking statements, updates, and links

Industry: N/A

Domaincullinantherapeutics.com

Year Founded2016

Employees51 - 200

Annual Revenue$15M - $25M

Cullinan Therapeutics

Cullinan Therapeutics (including company regionals)

cullinantherapeutics.com

See more website traffic and engagement information

Cullinan Therapeutics Revenue up to March 2026 is 15M - 25M

revenue generated by Cullinan Therapeutics top domains

Cullinan Therapeutics top domains revenue over 3 years

Revenue for Cullinan Therapeutics top domains

cullinantherapeutics.com15M - 25M

See more with Sales Intelligence

Total visits to Cullinan Therapeutics's top domains

Understand Cullinan Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

cullinantherapeutics.com6.1K

See more with Sales Intelligence

Avg. visit duration in Cullinan Therapeutics's top domains

Analyze Cullinan Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

cullinantherapeutics.com00:01:28

See more with Sales Intelligence

Avg. pageviews on Cullinan Therapeutics's top domains

See how Cullinan Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

cullinantherapeutics.com2.08

See more with Sales Intelligence

Cullinan Therapeutics top competitors by domain

Top similar sites in March 2026, ranked by their affinity

fiercebiotech.comCompany NameFierceBiotechEmployees51 - 200HQUnited States, Missouri, Lees SummitAnnual revenue$1M - $2MTotal visits783KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Cullinan Therapeutics

These are the website technologies, by industry, used by Cullinan Therapeutics top domains

Email Services (3)

Microsoft Exchange Online

Payment & Currencies (3)

PayPal

Widget (3)

Twemoji

Audio Video Media (2)

YouTube

More Technologies

7

See all

News & Signals from Cullinan Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCullinan Therapeutics, Inc is developing CLN-978 for systemic lupus erythematosus and rheumatoid arthritis.In addition to Sjögren's, Cullinan is developing CLN-978 for systemic lupus erythematosus and rheumatoid arthritis, two diseases also thought to be driven by self-reactive antibodies produced by B-cells.

NewsCullinan Therapeutics, Inc attends event 2025 ASH Annual Meeting.Cullinan Therapeutics to participate in upcoming investor conferences and host analyst and investor event at 2025 ASH Annual Meeting.

NewsCullinan Therapeutics, Inc attended event Stifel 2025 Virtual Immunology and Inflammation Forum on Sep 12th '25.CAMBRIDGE, Mass., Sept. 12, 2025 (GLOBE NEWSWIRE) - Cullinan Therapeutics, Inc. (Nasdaq: CGEM; "Cullinan"), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced that Jeffrey Jones, M.D., M.B.A., Chief Medical Officer, will participate in a fireside chat at the Stifel 2025 Virtual Immunology and Inflammation Forum on Tuesday, September 16, 2025, at 9:30 a.m. ET.